BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:19 PM
 | 
Aug 30, 2012
 |  BC Extra  |  Company News

Bayer seeks approval of regorafenib in GIST

Bayer AG (Xetra:BAYN) submitted an NDA to FDA for regorafenib to treat metastatic and/or unresectable gastrointestinal stromal tumors (GIST) in patients...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >